155 related articles for article (PubMed ID: 24531750)
1. T lymphocytes restrain spontaneous metastases in permanent dormancy.
Romero I; Garrido C; Algarra I; Collado A; Garrido F; Garcia-Lora AM
Cancer Res; 2014 Apr; 74(7):1958-68. PubMed ID: 24531750
[TBL] [Abstract][Full Text] [Related]
2. Metastases in immune-mediated dormancy: a new opportunity for targeting cancer.
Romero I; Garrido F; Garcia-Lora AM
Cancer Res; 2014 Dec; 74(23):6750-7. PubMed ID: 25411345
[TBL] [Abstract][Full Text] [Related]
3. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
4. Regulatory role of T lymphocytes and NK cells in tumor allograft development.
Sobotková E; Nouza K
Neoplasma; 1993; 40(2):75-80. PubMed ID: 8350958
[TBL] [Abstract][Full Text] [Related]
5. Effect of MHC class-I transfection on local tumor growth and metastasis in an H-2-negative clone derived from a chemically induced fibrosarcoma.
Mialdea MJ; Martin J; Gaforio JJ; Algarra I; Pérez M; Gonzalez A; Ljunggren HG; Garrido F
Int J Cancer; 1992 Aug; 52(1):153-8. PubMed ID: 1500219
[TBL] [Abstract][Full Text] [Related]
6. [Chimeric T cell receptor N29gamma redirect T lymphocytes response specific to p185HER2 in A murine model of metastatic breast cancer].
Li SP; Urban FA; Macgregor JN; Hughes DP; McDonagh KT
Ai Zheng; 2004 Nov; 23(11 Suppl):1370-5. PubMed ID: 15566639
[TBL] [Abstract][Full Text] [Related]
7. Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants.
Garcia-Lora A; Algarra I; Gaforio JJ; Ruiz-Cabello F; Garrido F
Int J Cancer; 2001 Jan; 91(1):109-19. PubMed ID: 11149409
[TBL] [Abstract][Full Text] [Related]
8. A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma.
Pérez M; Algarra I; Ljunggren HG; Caballero A; Mialdea MJ; Gaforio JJ; Klein G; Kärre K; Garrido F
Int J Cancer; 1990 Aug; 46(2):258-61. PubMed ID: 2116997
[TBL] [Abstract][Full Text] [Related]
9. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
Treves AJ; Cohen IR; Feldman M
Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
[TBL] [Abstract][Full Text] [Related]
10. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003
[TBL] [Abstract][Full Text] [Related]
11. Fibrosarcoma cells expressing allogeneic MHC Class II antigens induce protective antitumor immunity.
Leach DR; Callahan GN
J Immunol; 1995 Jan; 154(2):738-43. PubMed ID: 7814880
[TBL] [Abstract][Full Text] [Related]
12. MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy.
Romero I; Garrido C; Algarra I; Chamorro V; Collado A; Garrido F; Garcia-Lora AM
Front Immunol; 2018; 9():102. PubMed ID: 29434605
[TBL] [Abstract][Full Text] [Related]
13. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
14. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors.
Talmadge JE; Fidler IJ
J Natl Cancer Inst; 1982 Oct; 69(4):975-80. PubMed ID: 6750200
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
[TBL] [Abstract][Full Text] [Related]
17. [Antitumor concomitant immunity: a possible metastasis control mechanism].
Ruggiero RA; Bustuoadad OD; Bonfil RD; Sordelli DO; Fontan P; Meiss RP; Pasqualini CD
Medicina (B Aires); 1989; 49(3):277-81. PubMed ID: 2487422
[TBL] [Abstract][Full Text] [Related]
18. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines.
Pulaski BA; Ostrand-Rosenberg S
Cancer Res; 1998 Apr; 58(7):1486-93. PubMed ID: 9537252
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy eradicates metastases with reversible defects in MHC class I expression.
Garrido C; Romero I; Berruguilla E; Cancela B; Algarra I; Collado A; García-Lora A; Garrido F
Cancer Immunol Immunother; 2011 Sep; 60(9):1257-68. PubMed ID: 21553283
[TBL] [Abstract][Full Text] [Related]
20. Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants.
Mahalingam M; Ugen KE; Kao KJ; Klein PA
Cancer Res; 1988 Mar; 48(6):1460-4. PubMed ID: 3345518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
